Literature DB >> 30193100

The Akt-SRPK-SR Axis Constitutes a Major Pathway in Transducing EGF Signaling to Regulate Alternative Splicing in the Nucleus.

Zhihong Zhou, Jinsong Qiu, Wen Liu, Yu Zhou, Ryan M Plocinik, Hairi Li, Qidong Hu, Gourisanker Ghosh, Joseph A Adams, Michael G Rosenfeld, Xiang-Dong Fu.   

Abstract

Entities:  

Year:  2018        PMID： 30193100      PMCID： PMC6173192          DOI： 10.1016/j.molcel.2018.08.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN： 1097-2765            Impact factor:   17.970


× No keyword cloud information.
  4 in total

1.  RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling.

Authors:  Sunkyung Choi; Hyo Seong Lee; Namjoon Cho; Inyoung Kim; Seongmin Cheon; Chungoo Park; Eun-Mi Kim; Wantae Kim; Kee K Kim
Journal:  Nucleic Acids Res       Date:  2022-08-26       Impact factor: 19.160

2.  SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer.

Authors:  Jing-Qiang Huang; He-Feng Li; Li-Yun Gong; Jing Zhu; Jun-Wei Song; Xian-Bin Zhang; Peng Gong; Qiu-Yu Liu; Chun-Hui Zhou; Liang Wang
Journal:  J Transl Med       Date:  2021-06-30       Impact factor: 5.531

3.  Clinical and functional significance of CHK1-S, an alternatively spliced isoform of the CHK1 gene, in hepatocellular carcinoma.

Authors:  Guanghui Hu; Shuren Wang; Yu Wang; Yang Gao; Hongxia Zhu; Mei Liu; Ningzhi Xu; Liming Wang
Journal:  J Cancer       Date:  2020-01-17       Impact factor: 4.207

4.  Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer.

Authors:  Xin Li; Shaoyu Yang; Minna Zhang; Shuhuan Xie; Zefeng Xie
Journal:  Eur J Histochem       Date:  2019-12-11       Impact factor: 3.188
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.